Asia Pacific to Witness High CAGR in the Hyaluronic Acid Market
According to Custom Market Insights (CMI), The Global Hyaluronic Acid Market was estimated at USD 1.1 billion in 2021 and is anticipated to reach around USD 2.6 billion by 2030, growing at a CAGR of roughly 8% between 2022 and 2030. Our research report offers a 360-degree view of the Hyaluronic Acid market’s drivers and restraints, coupled with their impact on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Hyaluronic Acid market.
To learn more about this report, Request a Free sample
Hyaluronic Acid Market: Overview
The anionic, non-sulfated glycosaminoglycan hyaluronic acid, commonly known as hyaluronan, is found in large quantities in connective, epithelial, and neural tissues. Hyaluronic acid, a crucial component of articular cartilage, coats each cartilage cell like a glove (chondrocyte). Because these aggregates use water, cartilage is more durable (its resistance to compression). Hyaluronan in cartilage has a decreasing molecular weight (size) as it ages, but its quantity rises.
Hyaluronic acid occurs naturally in the human body (HA). The joints and eyes contain the highest concentrations of HA. The substance has the ability to keep skin supple and moisturized. As a result, many cosmetic surgeons employ it as an injectable to postpone the appearance of ageing on the skin.
Browse the full “Hyaluronic Acid Market Size, Trends and Insights By Grade (Food, Cosmetic, Pharmaceutical), By Application (Pharmaceutical API, Aesthetics, Osteoarthritis, Cosmetics, Ophthalmology, Dietary Supplements), By End-users (Pharmaceuticals Industry, Cosmetic Surgery Centers, Dermatology Clinics, Food Industry, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032 “ report at https://www.custommarketinsights.com/report/hyaluronic-acid-market/
Growth Factors
Hyaluronic acid is well known for its positive effects on the skin, including the reduction of fine lines, wrinkles, redness, and dermatitis, as well as the relief of dry skin. Hyaluronic acid is a great moisturizer since it aids in the retention of 1,000 times its weight in water within the skin cells. It helps reduce free radicals, maintain skin suppleness, and increase collagen formation in the skin. It also functions as a humectant, a type of hygroscopic substance used in cosmetics that pulls moisture from the environment.
As a person ages, hyaluronic acid and collagen are gradually lost, and the skin is more susceptible to dehydration. The protective skin barrier might become breached due to climatic factors, UV radiation, and pollution, which raises the need for hyaluronic acid. Supplemental hyaluronic acid keeps water from evaporating, giving the body more hyaluronic acid to integrate into the skin. The hydration of the skin can be greatly increased with an average dose of 120–240 mg per day for at least a month. It is frequently used in personal care and cosmetic items like lipstick, eye shadow, foundation, shampoo, hair conditioner, styling gel, facial creams, masks, serums, and moisturizers.
Segmental Overview
The market for Hyaluronic Acid is segmented into grade, application, and end-user. Based on grade, the cosmetic segment led the market in 2021. Due to its moisturizing and film-forming qualities, hyaluronic acid is utilized in cosmetics. By reducing flaking and restoring suppleness, it improves the appearance of dry or damaged skin, minimizing the visibility of wrinkles, fine lines, redness, and dermatitis. Additionally, aqueous (water) components of cosmetics and personal care items are thickened with hyaluronic acid.
Based on application, the osteoarthritis (OA) segment held the dominant market share in 2021. Products containing hyaluronic acid are used to treat osteoarthritis (OA) of the knee. Since hyaluronic acid is an affordable and useful pain management option, the market for it is expected to expand significantly in the near future. One of the most prevalent orthopaedic conditions and the main cause of impairment in the elderly population is knee osteoarthritis.
To learn more about this report, Request a Free sample
Regional Overview
In 2021, North America dominated the industry globally, contributing more than 40% of the total revenue. This is because a sizable portion of the population is elderly, who are more prone to diseases including osteoarthritis, vesicoureteral reflux, and cataracts. Furthermore, a significant component in the big proportion of North America is the rising demand for minimally invasive aesthetic procedures.
The Asia Pacific region is anticipated to experience the fastest CAGR over the projected period due to the high levels of unmet medical requirements in developing nations like South Korea and China, expanding awareness of the uses of minimally invasive procedures, and rising disposable income. A sizable market for anti-ageing goods and services is provided by the expanding elderly populations in China and Japan. Demand is fueled by growing knowledge of hyaluronan’s uses and effectiveness. Additionally, Asians want a volumized appearance and are influenced by western beauty ideals. The regional sector has increased as a result.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 1.1 Billion |
| Projected Market Size in 2030 | USD 2.6 Billion |
| Market Size in 2022 | USD 1.26 Billion |
| CAGR Growth Rate | 8% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Allergan, Genzyme Corporation, Sanofi, Anika Therapeutics Inc., Salix Pharmaceuticals, F. Hoffmann-La Roche Ag, Seikagaku Corporation, Galderma Laboratories L.P., Smith & Nephew Plc, Zimmer Biomet, Ferring B.V., HTL Biotechnology, Lifecore Biomedical Llc, Shiseido Company Limited, LG Life Sciences Ltd (LG Chem.), Bloomage Biotechnology Corporation Limited, Maruha Nichiro Inc., and Others |
| Key Segment | By Grade , Application, End-users, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Competitive Landscape
The growing acceptance of non-invasive cosmetic treatments like Botox and hyaluronic acid injections is fueling the market. Market expansion is predicted to be fueled by new product developments, increased business strategy implementation by leading market players, including mergers and acquisitions, and other factors throughout the course of the forecast period.
- 2021: HYA-ACT, a line of three separate hyaluronic acid products from Royal DSM, will go on sale soon. With this new line, Royal DSM is strengthening its hyaluronic acid portfolio to meet the market’s increasing demand for dependable, minimally intrusive, and efficient beauty care products.
Some of the prominent players
- Allergan
- Genzyme Corporation
- Sanofi
- Anika Therapeutics, Inc.
- Salix Pharmaceuticals
- Hoffmann-La Roche Ag
- Seikagaku Corporation
- Galderma Laboratories L.P.
- Smith & Nephew Plc
- Zimmer Biomet
- Ferring B.V.
- HTL Biotechnology
- Lifecore Biomedical, Llc
- Shiseido Company, Limited
- LG Life Sciences Ltd (LG Chem.)
- Bloomage Biotechnology Corporation Limited
- Maruha Nichiro, Inc.
The global Hyaluronic Acid market is segmented as follows:
By Grade
- Food
- Cosmetic
- Pharmaceutical
By Application
- Pharmaceutical API
- Aesthetics
- Osteoarthritis
- Cosmetics
- Ophthalmology
- Dietary Supplements
By End-users
- Pharmaceuticals Industry
- Cosmetic Surgery Centers
- Dermatology Clinics
- Food Industry
- Others
By Region
North America
- The U.S.
- Canada
- Mexico
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America